Akari Therapeutics (AKTX) Depreciation & Amortization (CF) (2014 - 2024)

Akari Therapeutics (AKTX) reported Depreciation & Amortization (CF) of $1000.0 for Q4 2024, little changed on a YoY basis from $1000.0 in Q1 2024, and down 92.31% sequentially from $13000.0 in Q1 2024.

Akari Therapeutics (AKTX) Depreciation & Amortization (CF) (2014 - 2024) Analysis & Trends

Akari Therapeutics (AKTX) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $1000.0 in Q4 2024.

  • For the quarter ending Q4 2024, Depreciation & Amortization (CF) changed 0.0% year-over-year to $1000.0; the trailing twelve-month figure through Sep 2025 stood at $1000.0 (down 92.86% YoY), and the FY2024 full-year result was $14000.0, up 250.0% from the prior year.
  • Depreciation & Amortization (CF) slipped to $1000.0 in Q4 2024, from $13000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $13000.0 in Q1 2024 to a low of $986.0 in Q3 2020.
  • A 3-year average of $2690.7 and a median of $1000.0 in 2020 frame the typical range for Depreciation & Amortization (CF).
  • Across the five-year window, Depreciation & Amortization (CF) slumped 78.69% in 2020 and soared 1200.0% in 2024, its largest moves.
  • Tracing AKTX's Depreciation & Amortization (CF) over 3 years: stood at $1000.0 in 2020, then changed by 0.0% to $1000.0 in 2023, then changed by 0.0% to $1000.0 in 2024.
  • Business Quant data shows AKTX's Depreciation & Amortization (CF) at $1000.0 in Q4 2024, $13000.0 in Q1 2024, and $1000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 196,658.72
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 41.14 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 55.90 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 123.20 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 2.20 Mn
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 1,000.00
Dec 31, 2024 1,000.00
Mar 31, 2024 13,000.00
Mar 31, 2024 13,000.00
Dec 31, 2023 1,000.00
Dec 31, 2023 1,000.00
Sep 30, 2023 1,000.00
Sep 30, 2023 1,000.00
Jun 30, 2023 1,000.00
Jun 30, 2023 1,000.00
Mar 31, 2023 1,000.00
Mar 31, 2023 1,000.00
Dec 31, 2020 1,000.00
Dec 31, 2020 1,000.00
Sep 30, 2020 986.00
Sep 30, 2020 986.00
Jun 30, 2020 3,044.00
Jun 30, 2020 3,044.00
Mar 31, 2020 3,877.00
Mar 31, 2020 3,877.00